Global Angiopoietin 2 Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Angiopoietin 2 market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Angiopoietin 2 industry chain, the market status of Hospital (Atu-111, BI-836880), Clinic (Atu-111, BI-836880), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Angiopoietin 2.
Regionally, the report analyzes the Angiopoietin 2 markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Angiopoietin 2 market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Angiopoietin 2 market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Angiopoietin 2 industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Atu-111, BI-836880).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Angiopoietin 2 market.
Regional Analysis: The report involves examining the Angiopoietin 2 market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Angiopoietin 2 market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Angiopoietin 2:
Company Analysis: Report covers individual Angiopoietin 2 manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Angiopoietin 2 This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Angiopoietin 2. It assesses the current state, advancements, and potential future developments in Angiopoietin 2 areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Angiopoietin 2 market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Angiopoietin 2 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Angiopoietin 2 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Angiopoietin 2, with price, sales, revenue and global market share of Angiopoietin 2 from 2019 to 2024.
Chapter 3, the Angiopoietin 2 competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angiopoietin 2 breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Angiopoietin 2 market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Angiopoietin 2.
Chapter 14 and 15, to describe Angiopoietin 2 sales channel, distributors, customers, research findings and conclusion.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The Global Info Research report includes an overview of the development of the Angiopoietin 2 industry chain, the market status of Hospital (Atu-111, BI-836880), Clinic (Atu-111, BI-836880), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Angiopoietin 2.
Regionally, the report analyzes the Angiopoietin 2 markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Angiopoietin 2 market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Angiopoietin 2 market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Angiopoietin 2 industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Atu-111, BI-836880).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Angiopoietin 2 market.
Regional Analysis: The report involves examining the Angiopoietin 2 market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Angiopoietin 2 market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Angiopoietin 2:
Company Analysis: Report covers individual Angiopoietin 2 manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Angiopoietin 2 This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Clinic).
Technology Analysis: Report covers specific technologies relevant to Angiopoietin 2. It assesses the current state, advancements, and potential future developments in Angiopoietin 2 areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Angiopoietin 2 market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Angiopoietin 2 market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Atu-111
- BI-836880
- LY-3127804
- MEDI-3617
- Others
- Hospital
- Clinic
- Others
- Amgen Inc.
- AnGes MG, Inc.
- Boehringer Ingelheim GmbH
- Eli Lilly and Company
- F. Hoffmann-La Roche Ltd.
- MedImmune, LLC
- Regeneron Pharmaceuticals, Inc.
- RXi Pharmaceuticals Corporation
- Silence Therapeutics Plc
- Synergys Biotherapeutics, Inc.
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Angiopoietin 2 product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Angiopoietin 2, with price, sales, revenue and global market share of Angiopoietin 2 from 2019 to 2024.
Chapter 3, the Angiopoietin 2 competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Angiopoietin 2 breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Angiopoietin 2 market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Angiopoietin 2.
Chapter 14 and 15, to describe Angiopoietin 2 sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Angiopoietin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Angiopoietin 2 Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Atu-111
1.3.3 BI-836880
1.3.4 LY-3127804
1.3.5 MEDI-3617
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Angiopoietin 2 Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Angiopoietin 2 Market Size & Forecast
1.5.1 Global Angiopoietin 2 Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Angiopoietin 2 Sales Quantity (2019-2030)
1.5.3 Global Angiopoietin 2 Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Amgen Inc.
2.1.1 Amgen Inc. Details
2.1.2 Amgen Inc. Major Business
2.1.3 Amgen Inc. Angiopoietin 2 Product and Services
2.1.4 Amgen Inc. Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amgen Inc. Recent Developments/Updates
2.2 AnGes MG, Inc.
2.2.1 AnGes MG, Inc. Details
2.2.2 AnGes MG, Inc. Major Business
2.2.3 AnGes MG, Inc. Angiopoietin 2 Product and Services
2.2.4 AnGes MG, Inc. Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AnGes MG, Inc. Recent Developments/Updates
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business
2.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Product and Services
2.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Boehringer Ingelheim GmbH Recent Developments/Updates
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Angiopoietin 2 Product and Services
2.4.4 Eli Lilly and Company Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli Lilly and Company Recent Developments/Updates
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business
2.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product and Services
2.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
2.6 MedImmune, LLC
2.6.1 MedImmune, LLC Details
2.6.2 MedImmune, LLC Major Business
2.6.3 MedImmune, LLC Angiopoietin 2 Product and Services
2.6.4 MedImmune, LLC Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 MedImmune, LLC Recent Developments/Updates
2.7 Regeneron Pharmaceuticals, Inc.
2.7.1 Regeneron Pharmaceuticals, Inc. Details
2.7.2 Regeneron Pharmaceuticals, Inc. Major Business
2.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product and Services
2.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
2.8 RXi Pharmaceuticals Corporation
2.8.1 RXi Pharmaceuticals Corporation Details
2.8.2 RXi Pharmaceuticals Corporation Major Business
2.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Product and Services
2.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 RXi Pharmaceuticals Corporation Recent Developments/Updates
2.9 Silence Therapeutics Plc
2.9.1 Silence Therapeutics Plc Details
2.9.2 Silence Therapeutics Plc Major Business
2.9.3 Silence Therapeutics Plc Angiopoietin 2 Product and Services
2.9.4 Silence Therapeutics Plc Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Silence Therapeutics Plc Recent Developments/Updates
2.10 Synergys Biotherapeutics, Inc.
2.10.1 Synergys Biotherapeutics, Inc. Details
2.10.2 Synergys Biotherapeutics, Inc. Major Business
2.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Product and Services
2.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Synergys Biotherapeutics, Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANGIOPOIETIN 2 BY MANUFACTURER
3.1 Global Angiopoietin 2 Sales Quantity by Manufacturer (2019-2024)
3.2 Global Angiopoietin 2 Revenue by Manufacturer (2019-2024)
3.3 Global Angiopoietin 2 Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Angiopoietin 2 by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Angiopoietin 2 Manufacturer Market Share in 2023
3.4.2 Top 6 Angiopoietin 2 Manufacturer Market Share in 2023
3.5 Angiopoietin 2 Market: Overall Company Footprint Analysis
3.5.1 Angiopoietin 2 Market: Region Footprint
3.5.2 Angiopoietin 2 Market: Company Product Type Footprint
3.5.3 Angiopoietin 2 Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Angiopoietin 2 Market Size by Region
4.1.1 Global Angiopoietin 2 Sales Quantity by Region (2019-2030)
4.1.2 Global Angiopoietin 2 Consumption Value by Region (2019-2030)
4.1.3 Global Angiopoietin 2 Average Price by Region (2019-2030)
4.2 North America Angiopoietin 2 Consumption Value (2019-2030)
4.3 Europe Angiopoietin 2 Consumption Value (2019-2030)
4.4 Asia-Pacific Angiopoietin 2 Consumption Value (2019-2030)
4.5 South America Angiopoietin 2 Consumption Value (2019-2030)
4.6 Middle East and Africa Angiopoietin 2 Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Angiopoietin 2 Sales Quantity by Type (2019-2030)
5.2 Global Angiopoietin 2 Consumption Value by Type (2019-2030)
5.3 Global Angiopoietin 2 Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Angiopoietin 2 Sales Quantity by Application (2019-2030)
6.2 Global Angiopoietin 2 Consumption Value by Application (2019-2030)
6.3 Global Angiopoietin 2 Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Angiopoietin 2 Sales Quantity by Type (2019-2030)
7.2 North America Angiopoietin 2 Sales Quantity by Application (2019-2030)
7.3 North America Angiopoietin 2 Market Size by Country
7.3.1 North America Angiopoietin 2 Sales Quantity by Country (2019-2030)
7.3.2 North America Angiopoietin 2 Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Angiopoietin 2 Sales Quantity by Type (2019-2030)
8.2 Europe Angiopoietin 2 Sales Quantity by Application (2019-2030)
8.3 Europe Angiopoietin 2 Market Size by Country
8.3.1 Europe Angiopoietin 2 Sales Quantity by Country (2019-2030)
8.3.2 Europe Angiopoietin 2 Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Angiopoietin 2 Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Angiopoietin 2 Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Angiopoietin 2 Market Size by Region
9.3.1 Asia-Pacific Angiopoietin 2 Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Angiopoietin 2 Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Angiopoietin 2 Sales Quantity by Type (2019-2030)
10.2 South America Angiopoietin 2 Sales Quantity by Application (2019-2030)
10.3 South America Angiopoietin 2 Market Size by Country
10.3.1 South America Angiopoietin 2 Sales Quantity by Country (2019-2030)
10.3.2 South America Angiopoietin 2 Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Angiopoietin 2 Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Angiopoietin 2 Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Angiopoietin 2 Market Size by Country
11.3.1 Middle East & Africa Angiopoietin 2 Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Angiopoietin 2 Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Angiopoietin 2 Market Drivers
12.2 Angiopoietin 2 Market Restraints
12.3 Angiopoietin 2 Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Angiopoietin 2 and Key Manufacturers
13.2 Manufacturing Costs Percentage of Angiopoietin
13.3 Angiopoietin 2 Production Process
13.4 Angiopoietin 2 Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Angiopoietin 2 Typical Distributors
14.3 Angiopoietin 2 Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Angiopoietin
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Angiopoietin 2 Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Atu-111
1.3.3 BI-836880
1.3.4 LY-3127804
1.3.5 MEDI-3617
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Angiopoietin 2 Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Others
1.5 Global Angiopoietin 2 Market Size & Forecast
1.5.1 Global Angiopoietin 2 Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Angiopoietin 2 Sales Quantity (2019-2030)
1.5.3 Global Angiopoietin 2 Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Amgen Inc.
2.1.1 Amgen Inc. Details
2.1.2 Amgen Inc. Major Business
2.1.3 Amgen Inc. Angiopoietin 2 Product and Services
2.1.4 Amgen Inc. Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Amgen Inc. Recent Developments/Updates
2.2 AnGes MG, Inc.
2.2.1 AnGes MG, Inc. Details
2.2.2 AnGes MG, Inc. Major Business
2.2.3 AnGes MG, Inc. Angiopoietin 2 Product and Services
2.2.4 AnGes MG, Inc. Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 AnGes MG, Inc. Recent Developments/Updates
2.3 Boehringer Ingelheim GmbH
2.3.1 Boehringer Ingelheim GmbH Details
2.3.2 Boehringer Ingelheim GmbH Major Business
2.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Product and Services
2.3.4 Boehringer Ingelheim GmbH Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Boehringer Ingelheim GmbH Recent Developments/Updates
2.4 Eli Lilly and Company
2.4.1 Eli Lilly and Company Details
2.4.2 Eli Lilly and Company Major Business
2.4.3 Eli Lilly and Company Angiopoietin 2 Product and Services
2.4.4 Eli Lilly and Company Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Eli Lilly and Company Recent Developments/Updates
2.5 F. Hoffmann-La Roche Ltd.
2.5.1 F. Hoffmann-La Roche Ltd. Details
2.5.2 F. Hoffmann-La Roche Ltd. Major Business
2.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product and Services
2.5.4 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 F. Hoffmann-La Roche Ltd. Recent Developments/Updates
2.6 MedImmune, LLC
2.6.1 MedImmune, LLC Details
2.6.2 MedImmune, LLC Major Business
2.6.3 MedImmune, LLC Angiopoietin 2 Product and Services
2.6.4 MedImmune, LLC Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 MedImmune, LLC Recent Developments/Updates
2.7 Regeneron Pharmaceuticals, Inc.
2.7.1 Regeneron Pharmaceuticals, Inc. Details
2.7.2 Regeneron Pharmaceuticals, Inc. Major Business
2.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product and Services
2.7.4 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
2.8 RXi Pharmaceuticals Corporation
2.8.1 RXi Pharmaceuticals Corporation Details
2.8.2 RXi Pharmaceuticals Corporation Major Business
2.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Product and Services
2.8.4 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 RXi Pharmaceuticals Corporation Recent Developments/Updates
2.9 Silence Therapeutics Plc
2.9.1 Silence Therapeutics Plc Details
2.9.2 Silence Therapeutics Plc Major Business
2.9.3 Silence Therapeutics Plc Angiopoietin 2 Product and Services
2.9.4 Silence Therapeutics Plc Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Silence Therapeutics Plc Recent Developments/Updates
2.10 Synergys Biotherapeutics, Inc.
2.10.1 Synergys Biotherapeutics, Inc. Details
2.10.2 Synergys Biotherapeutics, Inc. Major Business
2.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Product and Services
2.10.4 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Synergys Biotherapeutics, Inc. Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ANGIOPOIETIN 2 BY MANUFACTURER
3.1 Global Angiopoietin 2 Sales Quantity by Manufacturer (2019-2024)
3.2 Global Angiopoietin 2 Revenue by Manufacturer (2019-2024)
3.3 Global Angiopoietin 2 Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Angiopoietin 2 by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Angiopoietin 2 Manufacturer Market Share in 2023
3.4.2 Top 6 Angiopoietin 2 Manufacturer Market Share in 2023
3.5 Angiopoietin 2 Market: Overall Company Footprint Analysis
3.5.1 Angiopoietin 2 Market: Region Footprint
3.5.2 Angiopoietin 2 Market: Company Product Type Footprint
3.5.3 Angiopoietin 2 Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Angiopoietin 2 Market Size by Region
4.1.1 Global Angiopoietin 2 Sales Quantity by Region (2019-2030)
4.1.2 Global Angiopoietin 2 Consumption Value by Region (2019-2030)
4.1.3 Global Angiopoietin 2 Average Price by Region (2019-2030)
4.2 North America Angiopoietin 2 Consumption Value (2019-2030)
4.3 Europe Angiopoietin 2 Consumption Value (2019-2030)
4.4 Asia-Pacific Angiopoietin 2 Consumption Value (2019-2030)
4.5 South America Angiopoietin 2 Consumption Value (2019-2030)
4.6 Middle East and Africa Angiopoietin 2 Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Angiopoietin 2 Sales Quantity by Type (2019-2030)
5.2 Global Angiopoietin 2 Consumption Value by Type (2019-2030)
5.3 Global Angiopoietin 2 Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Angiopoietin 2 Sales Quantity by Application (2019-2030)
6.2 Global Angiopoietin 2 Consumption Value by Application (2019-2030)
6.3 Global Angiopoietin 2 Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Angiopoietin 2 Sales Quantity by Type (2019-2030)
7.2 North America Angiopoietin 2 Sales Quantity by Application (2019-2030)
7.3 North America Angiopoietin 2 Market Size by Country
7.3.1 North America Angiopoietin 2 Sales Quantity by Country (2019-2030)
7.3.2 North America Angiopoietin 2 Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Angiopoietin 2 Sales Quantity by Type (2019-2030)
8.2 Europe Angiopoietin 2 Sales Quantity by Application (2019-2030)
8.3 Europe Angiopoietin 2 Market Size by Country
8.3.1 Europe Angiopoietin 2 Sales Quantity by Country (2019-2030)
8.3.2 Europe Angiopoietin 2 Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Angiopoietin 2 Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Angiopoietin 2 Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Angiopoietin 2 Market Size by Region
9.3.1 Asia-Pacific Angiopoietin 2 Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Angiopoietin 2 Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Angiopoietin 2 Sales Quantity by Type (2019-2030)
10.2 South America Angiopoietin 2 Sales Quantity by Application (2019-2030)
10.3 South America Angiopoietin 2 Market Size by Country
10.3.1 South America Angiopoietin 2 Sales Quantity by Country (2019-2030)
10.3.2 South America Angiopoietin 2 Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Angiopoietin 2 Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Angiopoietin 2 Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Angiopoietin 2 Market Size by Country
11.3.1 Middle East & Africa Angiopoietin 2 Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Angiopoietin 2 Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Angiopoietin 2 Market Drivers
12.2 Angiopoietin 2 Market Restraints
12.3 Angiopoietin 2 Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Angiopoietin 2 and Key Manufacturers
13.2 Manufacturing Costs Percentage of Angiopoietin
13.3 Angiopoietin 2 Production Process
13.4 Angiopoietin 2 Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Angiopoietin 2 Typical Distributors
14.3 Angiopoietin 2 Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Angiopoietin 2 Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Angiopoietin 2 Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Inc. Major Business
Table 5. Amgen Inc. Angiopoietin 2 Product and Services
Table 6. Amgen Inc. Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Amgen Inc. Recent Developments/Updates
Table 8. AnGes MG, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. AnGes MG, Inc. Major Business
Table 10. AnGes MG, Inc. Angiopoietin 2 Product and Services
Table 11. AnGes MG, Inc. Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AnGes MG, Inc. Recent Developments/Updates
Table 13. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer Ingelheim GmbH Major Business
Table 15. Boehringer Ingelheim GmbH Angiopoietin 2 Product and Services
Table 16. Boehringer Ingelheim GmbH Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 18. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly and Company Major Business
Table 20. Eli Lilly and Company Angiopoietin 2 Product and Services
Table 21. Eli Lilly and Company Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Eli Lilly and Company Recent Developments/Updates
Table 23. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. F. Hoffmann-La Roche Ltd. Major Business
Table 25. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product and Services
Table 26. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 28. MedImmune, LLC Basic Information, Manufacturing Base and Competitors
Table 29. MedImmune, LLC Major Business
Table 30. MedImmune, LLC Angiopoietin 2 Product and Services
Table 31. MedImmune, LLC Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. MedImmune, LLC Recent Developments/Updates
Table 33. Regeneron Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Regeneron Pharmaceuticals, Inc. Major Business
Table 35. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product and Services
Table 36. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
Table 38. RXi Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 39. RXi Pharmaceuticals Corporation Major Business
Table 40. RXi Pharmaceuticals Corporation Angiopoietin 2 Product and Services
Table 41. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. RXi Pharmaceuticals Corporation Recent Developments/Updates
Table 43. Silence Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table 44. Silence Therapeutics Plc Major Business
Table 45. Silence Therapeutics Plc Angiopoietin 2 Product and Services
Table 46. Silence Therapeutics Plc Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Silence Therapeutics Plc Recent Developments/Updates
Table 48. Synergys Biotherapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Synergys Biotherapeutics, Inc. Major Business
Table 50. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product and Services
Table 51. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Synergys Biotherapeutics, Inc. Recent Developments/Updates
Table 53. Global Angiopoietin 2 Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 54. Global Angiopoietin 2 Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Angiopoietin 2 Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 56. Market Position of Manufacturers in Angiopoietin 2, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Angiopoietin 2 Production Site of Key Manufacturer
Table 58. Angiopoietin 2 Market: Company Product Type Footprint
Table 59. Angiopoietin 2 Market: Company Product Application Footprint
Table 60. Angiopoietin 2 New Market Entrants and Barriers to Market Entry
Table 61. Angiopoietin 2 Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Angiopoietin 2 Sales Quantity by Region (2019-2024) & (K Pcs)
Table 63. Global Angiopoietin 2 Sales Quantity by Region (2025-2030) & (K Pcs)
Table 64. Global Angiopoietin 2 Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Angiopoietin 2 Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Angiopoietin 2 Average Price by Region (2019-2024) & (USD/Pcs)
Table 67. Global Angiopoietin 2 Average Price by Region (2025-2030) & (USD/Pcs)
Table 68. Global Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 69. Global Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 70. Global Angiopoietin 2 Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Angiopoietin 2 Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Angiopoietin 2 Average Price by Type (2019-2024) & (USD/Pcs)
Table 73. Global Angiopoietin 2 Average Price by Type (2025-2030) & (USD/Pcs)
Table 74. Global Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 75. Global Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 76. Global Angiopoietin 2 Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Angiopoietin 2 Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Angiopoietin 2 Average Price by Application (2019-2024) & (USD/Pcs)
Table 79. Global Angiopoietin 2 Average Price by Application (2025-2030) & (USD/Pcs)
Table 80. North America Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 81. North America Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 82. North America Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 83. North America Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 84. North America Angiopoietin 2 Sales Quantity by Country (2019-2024) & (K Pcs)
Table 85. North America Angiopoietin 2 Sales Quantity by Country (2025-2030) & (K Pcs)
Table 86. North America Angiopoietin 2 Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Angiopoietin 2 Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 89. Europe Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 90. Europe Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 91. Europe Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 92. Europe Angiopoietin 2 Sales Quantity by Country (2019-2024) & (K Pcs)
Table 93. Europe Angiopoietin 2 Sales Quantity by Country (2025-2030) & (K Pcs)
Table 94. Europe Angiopoietin 2 Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Angiopoietin 2 Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 97. Asia-Pacific Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 98. Asia-Pacific Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 99. Asia-Pacific Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 100. Asia-Pacific Angiopoietin 2 Sales Quantity by Region (2019-2024) & (K Pcs)
Table 101. Asia-Pacific Angiopoietin 2 Sales Quantity by Region (2025-2030) & (K Pcs)
Table 102. Asia-Pacific Angiopoietin 2 Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Angiopoietin 2 Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 105. South America Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 106. South America Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 107. South America Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 108. South America Angiopoietin 2 Sales Quantity by Country (2019-2024) & (K Pcs)
Table 109. South America Angiopoietin 2 Sales Quantity by Country (2025-2030) & (K Pcs)
Table 110. South America Angiopoietin 2 Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Angiopoietin 2 Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 113. Middle East & Africa Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 114. Middle East & Africa Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 115. Middle East & Africa Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 116. Middle East & Africa Angiopoietin 2 Sales Quantity by Region (2019-2024) & (K Pcs)
Table 117. Middle East & Africa Angiopoietin 2 Sales Quantity by Region (2025-2030) & (K Pcs)
Table 118. Middle East & Africa Angiopoietin 2 Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Angiopoietin 2 Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Angiopoietin 2 Raw Material
Table 121. Key Manufacturers of Angiopoietin 2 Raw Materials
Table 122. Angiopoietin 2 Typical Distributors
Table 123. Angiopoietin 2 Typical Customers
Table 1. Global Angiopoietin 2 Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Angiopoietin 2 Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Amgen Inc. Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Inc. Major Business
Table 5. Amgen Inc. Angiopoietin 2 Product and Services
Table 6. Amgen Inc. Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Amgen Inc. Recent Developments/Updates
Table 8. AnGes MG, Inc. Basic Information, Manufacturing Base and Competitors
Table 9. AnGes MG, Inc. Major Business
Table 10. AnGes MG, Inc. Angiopoietin 2 Product and Services
Table 11. AnGes MG, Inc. Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. AnGes MG, Inc. Recent Developments/Updates
Table 13. Boehringer Ingelheim GmbH Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer Ingelheim GmbH Major Business
Table 15. Boehringer Ingelheim GmbH Angiopoietin 2 Product and Services
Table 16. Boehringer Ingelheim GmbH Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 18. Eli Lilly and Company Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly and Company Major Business
Table 20. Eli Lilly and Company Angiopoietin 2 Product and Services
Table 21. Eli Lilly and Company Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Eli Lilly and Company Recent Developments/Updates
Table 23. F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base and Competitors
Table 24. F. Hoffmann-La Roche Ltd. Major Business
Table 25. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Product and Services
Table 26. F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. F. Hoffmann-La Roche Ltd. Recent Developments/Updates
Table 28. MedImmune, LLC Basic Information, Manufacturing Base and Competitors
Table 29. MedImmune, LLC Major Business
Table 30. MedImmune, LLC Angiopoietin 2 Product and Services
Table 31. MedImmune, LLC Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. MedImmune, LLC Recent Developments/Updates
Table 33. Regeneron Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 34. Regeneron Pharmaceuticals, Inc. Major Business
Table 35. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Product and Services
Table 36. Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Regeneron Pharmaceuticals, Inc. Recent Developments/Updates
Table 38. RXi Pharmaceuticals Corporation Basic Information, Manufacturing Base and Competitors
Table 39. RXi Pharmaceuticals Corporation Major Business
Table 40. RXi Pharmaceuticals Corporation Angiopoietin 2 Product and Services
Table 41. RXi Pharmaceuticals Corporation Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. RXi Pharmaceuticals Corporation Recent Developments/Updates
Table 43. Silence Therapeutics Plc Basic Information, Manufacturing Base and Competitors
Table 44. Silence Therapeutics Plc Major Business
Table 45. Silence Therapeutics Plc Angiopoietin 2 Product and Services
Table 46. Silence Therapeutics Plc Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Silence Therapeutics Plc Recent Developments/Updates
Table 48. Synergys Biotherapeutics, Inc. Basic Information, Manufacturing Base and Competitors
Table 49. Synergys Biotherapeutics, Inc. Major Business
Table 50. Synergys Biotherapeutics, Inc. Angiopoietin 2 Product and Services
Table 51. Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Synergys Biotherapeutics, Inc. Recent Developments/Updates
Table 53. Global Angiopoietin 2 Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 54. Global Angiopoietin 2 Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Angiopoietin 2 Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 56. Market Position of Manufacturers in Angiopoietin 2, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Angiopoietin 2 Production Site of Key Manufacturer
Table 58. Angiopoietin 2 Market: Company Product Type Footprint
Table 59. Angiopoietin 2 Market: Company Product Application Footprint
Table 60. Angiopoietin 2 New Market Entrants and Barriers to Market Entry
Table 61. Angiopoietin 2 Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Angiopoietin 2 Sales Quantity by Region (2019-2024) & (K Pcs)
Table 63. Global Angiopoietin 2 Sales Quantity by Region (2025-2030) & (K Pcs)
Table 64. Global Angiopoietin 2 Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Angiopoietin 2 Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Angiopoietin 2 Average Price by Region (2019-2024) & (USD/Pcs)
Table 67. Global Angiopoietin 2 Average Price by Region (2025-2030) & (USD/Pcs)
Table 68. Global Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 69. Global Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 70. Global Angiopoietin 2 Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Angiopoietin 2 Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Angiopoietin 2 Average Price by Type (2019-2024) & (USD/Pcs)
Table 73. Global Angiopoietin 2 Average Price by Type (2025-2030) & (USD/Pcs)
Table 74. Global Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 75. Global Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 76. Global Angiopoietin 2 Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Angiopoietin 2 Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Angiopoietin 2 Average Price by Application (2019-2024) & (USD/Pcs)
Table 79. Global Angiopoietin 2 Average Price by Application (2025-2030) & (USD/Pcs)
Table 80. North America Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 81. North America Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 82. North America Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 83. North America Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 84. North America Angiopoietin 2 Sales Quantity by Country (2019-2024) & (K Pcs)
Table 85. North America Angiopoietin 2 Sales Quantity by Country (2025-2030) & (K Pcs)
Table 86. North America Angiopoietin 2 Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Angiopoietin 2 Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 89. Europe Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 90. Europe Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 91. Europe Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 92. Europe Angiopoietin 2 Sales Quantity by Country (2019-2024) & (K Pcs)
Table 93. Europe Angiopoietin 2 Sales Quantity by Country (2025-2030) & (K Pcs)
Table 94. Europe Angiopoietin 2 Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Angiopoietin 2 Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 97. Asia-Pacific Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 98. Asia-Pacific Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 99. Asia-Pacific Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 100. Asia-Pacific Angiopoietin 2 Sales Quantity by Region (2019-2024) & (K Pcs)
Table 101. Asia-Pacific Angiopoietin 2 Sales Quantity by Region (2025-2030) & (K Pcs)
Table 102. Asia-Pacific Angiopoietin 2 Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Angiopoietin 2 Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 105. South America Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 106. South America Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 107. South America Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 108. South America Angiopoietin 2 Sales Quantity by Country (2019-2024) & (K Pcs)
Table 109. South America Angiopoietin 2 Sales Quantity by Country (2025-2030) & (K Pcs)
Table 110. South America Angiopoietin 2 Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Angiopoietin 2 Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Angiopoietin 2 Sales Quantity by Type (2019-2024) & (K Pcs)
Table 113. Middle East & Africa Angiopoietin 2 Sales Quantity by Type (2025-2030) & (K Pcs)
Table 114. Middle East & Africa Angiopoietin 2 Sales Quantity by Application (2019-2024) & (K Pcs)
Table 115. Middle East & Africa Angiopoietin 2 Sales Quantity by Application (2025-2030) & (K Pcs)
Table 116. Middle East & Africa Angiopoietin 2 Sales Quantity by Region (2019-2024) & (K Pcs)
Table 117. Middle East & Africa Angiopoietin 2 Sales Quantity by Region (2025-2030) & (K Pcs)
Table 118. Middle East & Africa Angiopoietin 2 Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Angiopoietin 2 Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Angiopoietin 2 Raw Material
Table 121. Key Manufacturers of Angiopoietin 2 Raw Materials
Table 122. Angiopoietin 2 Typical Distributors
Table 123. Angiopoietin 2 Typical Customers
LIST OF FIGURES
Figure 1. Angiopoietin 2 Picture
Figure 2. Global Angiopoietin 2 Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Angiopoietin 2 Consumption Value Market Share by Type in 2023
Figure 4. Atu-111 Examples
Figure 5. BI-836880 Examples
Figure 6. LY-3127804 Examples
Figure 7. MEDI-3617 Examples
Figure 8. Others Examples
Figure 9. Global Angiopoietin 2 Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Angiopoietin 2 Consumption Value Market Share by Application in 2023
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Others Examples
Figure 14. Global Angiopoietin 2 Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Angiopoietin 2 Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Angiopoietin 2 Sales Quantity (2019-2030) & (K Pcs)
Figure 17. Global Angiopoietin 2 Average Price (2019-2030) & (USD/Pcs)
Figure 18. Global Angiopoietin 2 Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Angiopoietin 2 Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Angiopoietin 2 by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Angiopoietin 2 Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Angiopoietin 2 Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Angiopoietin 2 Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Angiopoietin 2 Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Angiopoietin 2 Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Angiopoietin 2 Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Angiopoietin 2 Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Angiopoietin 2 Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Angiopoietin 2 Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Angiopoietin 2 Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Angiopoietin 2 Average Price by Type (2019-2030) & (USD/Pcs)
Figure 33. Global Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Angiopoietin 2 Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Angiopoietin 2 Average Price by Application (2019-2030) & (USD/Pcs)
Figure 36. North America Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Angiopoietin 2 Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Angiopoietin 2 Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Angiopoietin 2 Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Angiopoietin 2 Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Angiopoietin 2 Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Angiopoietin 2 Consumption Value Market Share by Region (2019-2030)
Figure 56. China Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Angiopoietin 2 Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Angiopoietin 2 Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Angiopoietin 2 Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Angiopoietin 2 Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Angiopoietin 2 Market Drivers
Figure 77. Angiopoietin 2 Market Restraints
Figure 78. Angiopoietin 2 Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Angiopoietin 2 in 2023
Figure 81. Manufacturing Process Analysis of Angiopoietin 2
Figure 82. Angiopoietin 2 Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Angiopoietin 2 Picture
Figure 2. Global Angiopoietin 2 Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Angiopoietin 2 Consumption Value Market Share by Type in 2023
Figure 4. Atu-111 Examples
Figure 5. BI-836880 Examples
Figure 6. LY-3127804 Examples
Figure 7. MEDI-3617 Examples
Figure 8. Others Examples
Figure 9. Global Angiopoietin 2 Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global Angiopoietin 2 Consumption Value Market Share by Application in 2023
Figure 11. Hospital Examples
Figure 12. Clinic Examples
Figure 13. Others Examples
Figure 14. Global Angiopoietin 2 Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Angiopoietin 2 Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Angiopoietin 2 Sales Quantity (2019-2030) & (K Pcs)
Figure 17. Global Angiopoietin 2 Average Price (2019-2030) & (USD/Pcs)
Figure 18. Global Angiopoietin 2 Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Angiopoietin 2 Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Angiopoietin 2 by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 Angiopoietin 2 Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 Angiopoietin 2 Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global Angiopoietin 2 Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Angiopoietin 2 Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Angiopoietin 2 Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Angiopoietin 2 Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Angiopoietin 2 Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Angiopoietin 2 Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Angiopoietin 2 Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Angiopoietin 2 Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Angiopoietin 2 Average Price by Type (2019-2030) & (USD/Pcs)
Figure 33. Global Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Angiopoietin 2 Consumption Value Market Share by Application (2019-2030)
Figure 35. Global Angiopoietin 2 Average Price by Application (2019-2030) & (USD/Pcs)
Figure 36. North America Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Angiopoietin 2 Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Angiopoietin 2 Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Angiopoietin 2 Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Angiopoietin 2 Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Angiopoietin 2 Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Angiopoietin 2 Consumption Value Market Share by Region (2019-2030)
Figure 56. China Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Angiopoietin 2 Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Angiopoietin 2 Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Angiopoietin 2 Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Angiopoietin 2 Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Angiopoietin 2 Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa Angiopoietin 2 Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa Angiopoietin 2 Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. Angiopoietin 2 Market Drivers
Figure 77. Angiopoietin 2 Market Restraints
Figure 78. Angiopoietin 2 Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Angiopoietin 2 in 2023
Figure 81. Manufacturing Process Analysis of Angiopoietin 2
Figure 82. Angiopoietin 2 Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
